0001650840-21-000002.txt : 20211104 0001650840-21-000002.hdr.sgml : 20211104 20211104151916 ACCESSION NUMBER: 0001650840-21-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20211104 DATE AS OF CHANGE: 20211104 EFFECTIVENESS DATE: 20211104 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aerami Therapeutics Holdings, Inc. CENTRAL INDEX KEY: 0001650840 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-414428 FILM NUMBER: 211379593 BUSINESS ADDRESS: STREET 1: 2520 MERIDIAN PARKWAY STREET 2: SUITE 400 CITY: DURHAM STATE: NC ZIP: 27713 BUSINESS PHONE: 9195897495 MAIL ADDRESS: STREET 1: 2520 MERIDIAN PARKWAY STREET 2: SUITE 400 CITY: DURHAM STATE: NC ZIP: 27713 FORMER COMPANY: FORMER CONFORMED NAME: Dance Biopharm Holdings, Inc. DATE OF NAME CHANGE: 20150819 FORMER COMPANY: FORMER CONFORMED NAME: Dance BioPharm Holdings, Inc. DATE OF NAME CHANGE: 20150812 D/A 1 primary_doc.xml X0708 D/A LIVE 0001650840 Aerami Therapeutics Holdings, Inc. 2520 MERIDIAN PARKWAY SUITE 400 DURHAM NC NORTH CAROLINA 27713 9195897495 DELAWARE Dance Biopharm Holdings, Inc. Dance BioPharm Holdings, Inc. Corporation true ANNE C. WHITAKER 2520 MERIDIAN PARKWAY SUITE 400 DURHAM NC NORTH CAROLINA 27713 Director JOHN S. PATTON 2520 MERIDIAN PARKWAY SUITE 400 DURHAM NC NORTH CAROLINA 27713 Director STEVE THORNTON 2520 MERIDIAN PARKWAY SUITE 400 DURHAM NC NORTH CAROLINA 27713 Executive Officer Director ADAM STERN 2520 MERIDIAN PARKWAY SUITE 400 DURHAM NC NORTH CAROLINA 27713 Director BILL WELCH 2520 MERIDIAN PARKWAY SUITE 400 DURHAM NC NORTH CAROLINA 27713 Director K JEFFREY BELL 2520 MERIDIAN PARKWAY SUITE 400 DURHAM NC NORTH CAROLINA 27713 Executive Officer TIMM CROWDER 2520 MERIDIAN PARKWAY SUITE 400 DURHAM NC NORTH CAROLINA 27713 Executive Officer DARLENE DEPTULA-HICKS 2520 MERIDIAN PARKWAY SUITE 400 DURHAM NC NORTH CAROLINA 27713 Director Other Health Care Decline to Disclose 06b true 0001650840-21-000001 2021-09-17 false true false 0 AEGIS CAPITAL CORP. 15007 None None 810 7th AVENUE 22nd FLOOR NEW YORK NY NEW YORK 10019 All States false 22250560 22250560 0 false 238 2221056 0 Warrants to purchase up to 10% of the number of shares sold in the offering will be issued to Placement Agent for nominal consideration. 0 Proceeds to be used for working capital and genl corporate purposes, incl officer and employee salaries & director fees. A portion of proceeds to be used to compensate Placement Agent. Adam Stern, a director of issuer, is an affiliate of Placement Agent. false Aerami Therapeutics Holdings, Inc. /s/ Steven Thornton Steven Thornton Chief Executive Officer 2021-11-04